Abbott E-Mails Could Affect Patent Evergreening Suits
A series of e-mails obtained by the Wall Street Journal has revealed the extent to which some companies go to increase sales of their drugs. In the e-mails, Abbott executives discuss how to protect the company’s blockbuster AIDS drug Kaletra in an increasingly competitive marketplace.
The company considered several options, all of which...
To view the full article, register now.